Understanding Harm Reduction A New Paradigm for Treating Risky and Addictive Behavior
During this webinar you will learn how to:
-Discuss the core principles of integrative harm reduction psychotherapy.
-Identify the limitations of the disease model/ abstinence-only approach.
-Explain the clinical challenges associated with treating substance use disorders and limitations of the current treatment system in the United States.
Presenter
Andrew Tatarsky, PhD
Andrew Tatarsky has developed Integrative Harm Reduction Psychotherapy (IHRP) for treating the spectrum of risky and addictive behavior. IHRP brings psychoanalysis, CBT and mindfulness together in a harm reduction frame. The therapy has been described in his book, Harm Reduction Psychotherapy: A New Treatment for Drug and Alcohol Problems, and a series of papers. The book has been translated into Polish and Spanish. He holds a doctorate in clinical psychology from the City University of New York and is a graduate of New York University’s Postdoctoral Program in Psychoanalysis and Psychotherapy. He is Founder and Executive Director of the Center for Optimal Living in NYC, a treatment, education and professional training center based on IHRP. He is a founding board member and twice Past-President, Division on Addiction of New York State Psychological Association and Member of the Medical and Clinical Advisory Boards of the New York State Office of Alcoholism and Substance Abuse Services. Andrew has trained individuals and organizations in 18 countries. His writing, teaching, clinical work and leadership aim to promote a re-humanized view of addiction and a harm reduction continuum of care that will extend help to everyone who needs and wants it where ever they are ready to begin their positive change journeys.
Видео Understanding Harm Reduction A New Paradigm for Treating Risky and Addictive Behavior канала TheIRETAchannel
-Discuss the core principles of integrative harm reduction psychotherapy.
-Identify the limitations of the disease model/ abstinence-only approach.
-Explain the clinical challenges associated with treating substance use disorders and limitations of the current treatment system in the United States.
Presenter
Andrew Tatarsky, PhD
Andrew Tatarsky has developed Integrative Harm Reduction Psychotherapy (IHRP) for treating the spectrum of risky and addictive behavior. IHRP brings psychoanalysis, CBT and mindfulness together in a harm reduction frame. The therapy has been described in his book, Harm Reduction Psychotherapy: A New Treatment for Drug and Alcohol Problems, and a series of papers. The book has been translated into Polish and Spanish. He holds a doctorate in clinical psychology from the City University of New York and is a graduate of New York University’s Postdoctoral Program in Psychoanalysis and Psychotherapy. He is Founder and Executive Director of the Center for Optimal Living in NYC, a treatment, education and professional training center based on IHRP. He is a founding board member and twice Past-President, Division on Addiction of New York State Psychological Association and Member of the Medical and Clinical Advisory Boards of the New York State Office of Alcoholism and Substance Abuse Services. Andrew has trained individuals and organizations in 18 countries. His writing, teaching, clinical work and leadership aim to promote a re-humanized view of addiction and a harm reduction continuum of care that will extend help to everyone who needs and wants it where ever they are ready to begin their positive change journeys.
Видео Understanding Harm Reduction A New Paradigm for Treating Risky and Addictive Behavior канала TheIRETAchannel
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
IPCP Case Study - AdolescentMedication First: Integration of Opioid Use Disorder Treatment Across the Healthcare SystemThe Opioid Epidemic in Our Emergency Departments - Preventing Overdose and Supporting SurvivorsIRETA's Holiday Card 2015Psychiatric Aspects of MMT: Integrating the Medical Model with RecoveryTreating a Patient with a Co-Occurring DisorderPrescription Opioids: ReviewClinical and Ethical Issues Managing Suicide Risk with Individuals Using SubstancesThe Role of the Pharmacist in the Management of Substance Use DisordersUnderstanding the Addicted Patient in an ER SettingWhat Is the Right Choice When Prescribing Medication Assisted Treatment (MAT)?Engaging Reluctant Participants in SUD Group Counseling: “Gimmicks for Group”Referral to Treatment Part 1/2Addressing Adolescent Substance Use via TelehealthWorking with Justice-Involved YouthDigital Tour: Case Studies of SBIRT in ActionClinical Research on SBIRT and Integrative Healthcare at a Federally Qualified Health CenterTargeted Self CareSBIRT in Action - Accelerator for Healthcare IntegrationSBIRT and the Electronic Health Record Featuring Tom McLellanAntoine Douaihy, PhD: Pharmacology (Drug-Drug Interactions)